NIH Public Meeting on Norvir March-In Request - May 25, 2004 Statements Delivered by Speakers at the Meeting Statements from Supporters of the March-In Request Statement of James Love, President, Essential Inventions. Statement of Jerome Reichman, Bunyan S. Womble Professor of Law, Duke University School of Law. Statement of Bob Huff, Editor, GMHC Treatment Issues; Gay Men's Health Crisis. Statement of Dan Ravicher, Executive Director, Public Patent Foundation. Statements from those Opposed to the March-In Request Statement of former Senator Birch Bayh. Also of interest is Birch Bayh's 1997 Cellpro petition for a march-in, where he expressed quite different views. Statement of Jeffrey Leiden, President and COO, Pharmaceutical Products Group, Abbott Laboratories. Compare Leiden's comments on the relative investments by Abbott and the NIH on this comment on Public, Private investment in Norvir Statement of Norman Latker. Statement of Ted Poehler, Association of American Universities. Statement of John Erickson, Chief Scientific Officer, Sequoia Pharmaceuticals. News Coverage June 2, 2004. Bob Roehr for the Windy City Advocate. Norvir Patent Under Fire at NIH Meeting. May 27, 2004. Associated Press. Price of AIDS drug challenged. May 26, 2004. David Brown for the Washington Post. Group Says U.S. Should Claim AIDS Drug Patents. May 26, 2004. Bruce Japsen for the Chicago Tribune. Abbott defends price boost on AIDS drug at U.S. hearing. May 26, 2004. Dorsey Griffith for the Sacremento Bee. Plea issued on AIDS drug's 400% price hike. May 25, 2004. Randolph Schmid for the Associated Press. Advocates urge cutting cost of AIDS drug. May 25, 2004. Lisa Richwine for Reuters. Abbott defends AIDS drug price rise to U.S. panel. May 25, 2004. Bloomberg News. Abbott AIDS drug patent at issue. May 25, 2004. Maureen Groppe for Gannett. Debate targets U.S.-funded drugs. May 25, 2004. Emily Heil for Congress Daily. NIH weighing government authority over drug pricing May 24, 2004. Leila Abbound for the Wall Street Journal. Drug-Pricing Rules Face Review. May 24, 2004. Merrill Goozner. Abbot and AIDS Misc. May 27, 2004. James Love. Notes from the hearing. April 28, 2004. Essential Inventions Statement on Decision by NIH to Hold Public Meeting on Compulsory Licenses Remedy for Abbott's Abuse of Ritonavir Patents. April 28, 2004. Federal Register Notice of Public Meeting. Also available as a text file. Home | Ritonavir Page